
MorningRX: August 22, 2023
Poll finds Americans still struggle with health misinformation, CMS release new guidance on out-of-pocket Prescription Drug Cost Program, and experts call for continued masking in health care settings.
Health Misinformation Still an Issue for Many Americans
The majority of Americans still struggle to know whether health misinformation is true or false, according to a new poll conducted by the
“Most people aren’t true believers in the lies or the facts about health issues; they are in a muddled middle,” KFF President and CEO Drew Altman said in a release. “The public’s uncertainty leaves them vulnerable to misinformation but is also the opportunity to combat it.”
CMS Issues Guidance on Out-of-Pocket Prescription Drug Cost Program
The Centers for Medicare & Medicaid Services released a draft guidance outlining requirements and procedures for the Medicare Prescription Payment Plan,
“For people with Medicare Part D who face high costs early in the year, today’s announcement will ease the burden of out-of-pocket prescription drug costs,” HHS Secretary Xavier Becerra said in a release. “This is one more example of how the President’s prescription drug bill is reducing costs and increasing access to life-saving medicines for our Medicare beneficiaries.”
Experts Call for Continued Masking in Health Care Settings
A group of experts are calling for continued masking in health care settings due to the uncertain nature of the COVID-19 pandemic, according to a commentary published in the
“Our appreciation and understanding of both patient and health care system impacts associated with SARS-CoV-2 and other respiratory viruses have been reshaped as a result of the COVID-19 pandemic,” the authors wrote. “We should be mindful of continuing areas of uncertainty while integrating the lessons learned into our hospital-based practices to prevent harm to vulnerable patients rather than reverting to suboptimal prepandemic behaviors.”
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.